» Articles » PMID: 27429711

New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease

Overview
Publisher Wiley
Date 2016 Jul 19
PMID 27429711
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

In chronic kidney disease inflammatory processes and stimulation of immune cells result in overproduction of free radicals. In combination with a reduced antioxidant capacity this causes oxidative stress. This review focuses on current pathogenic concepts of oxidative stress for the decline of kidney function and development of cardiovascular complications. We discuss the impact of mitochondrial alterations and dysfunction, a pathogenic role for hyperuricemia, and disturbances of vitamin D metabolism and signal transduction. Recent antioxidant therapy options including the use of vitamin D and pharmacologic therapies for hyperuricemia are discussed. Finally, we review some new therapy options in diabetic nephropathy including antidiabetic agents (noninsulin dependent), plant antioxidants, and food components as alternative antioxidant therapies.

Citing Articles

Sodium-Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome.

Cortes-Camacho F, Zambrano-Vasquez O, Arechaga-Ocampo E, Castaneda-Sanchez J, Gonzaga-Sanchez J, Sanchez-Gloria J Antioxidants (Basel). 2024; 13(7).

PMID: 39061837 PMC: 11274291. DOI: 10.3390/antiox13070768.


Pathophysiological concepts and screening of cardiovascular disease in dialysis patients.

Echefu G, Stowe I, Burka S, Basu-Ray I, Kumbala D Front Nephrol. 2023; 3:1198560.

PMID: 37840653 PMC: 10570458. DOI: 10.3389/fneph.2023.1198560.


The Multi-Faceted Nature of Renalase for Mitochondrial Dysfunction Improvement in Cardiac Disease.

Stojanovic D, Stojanovic M, Milenkovic J, Velickov A, Ignjatovic A, Milojkovic M Cells. 2023; 12(12).

PMID: 37371077 PMC: 10297141. DOI: 10.3390/cells12121607.


Nrf2 Protein Serum Concentration in Human CKD Shows a Biphasic Behavior.

Rasmussen M, Hansen K, Scholze A Antioxidants (Basel). 2023; 12(4).

PMID: 37107307 PMC: 10135793. DOI: 10.3390/antiox12040932.


Arabic gum ameliorates systemic modulation in Alloxan monohydrate-induced diabetic rats.

Ibrahim R, Abdelhafez H, El-Shamy S, Eid F, Mashaal A Sci Rep. 2023; 13(1):5005.

PMID: 36973339 PMC: 10042862. DOI: 10.1038/s41598-023-31897-x.


References
1.
Karamouzis I, Sarafidis P, Karamouzis M, Iliadis S, Haidich A, Sioulis A . Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol. 2007; 28(3):397-404. DOI: 10.1159/000112413. View

2.
Cui W, Bai Y, Miao X, Luo P, Chen Q, Tan Y . Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation. Oxid Med Cell Longev. 2012; 2012:821936. PMC: 3461640. DOI: 10.1155/2012/821936. View

3.
Luchi W, Shimizu M, Canale D, Gois P, de Braganca A, Volpini R . Vitamin D deficiency is a potential risk factor for contrast-induced nephropathy. Am J Physiol Regul Integr Comp Physiol. 2015; 309(3):R215-22. DOI: 10.1152/ajpregu.00526.2014. View

4.
Yang S, Xiao L, Xu B, Xu X, Liu F, Sun L . Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis. Ren Fail. 2014; 36(5):722-31. DOI: 10.3109/0886022X.2014.890858. View

5.
Bhat M, Ismail A . Vitamin D treatment protects against and reverses oxidative stress induced muscle proteolysis. J Steroid Biochem Mol Biol. 2015; 152:171-9. DOI: 10.1016/j.jsbmb.2015.05.012. View